A decade after the discovery of electrospray and matrix-assisted laser deso
rption ionization (MALDI), methods that finally allowed gentle ionization o
f large biomolecules, mass spectrometry has become a powerful tool in prote
in analysis and the key technology in the emerging field of proteomics. The
success of mass spectrometry is driven both by innovative instrumentation
designs, especially those operating on the time-of-flight or ion-trapping p
rinciples, and by large-scale biochemical strategies, which use mass spectr
ometry to detect the isolated proteins. Any human protein can now be identi
fied directly from genome databases on the basis of minimal data derived by
mass spectrometry. As has already happened in genomics, increased automati
on of sample handling, analysis, and the interpretation of results will gen
erate an avalanche of qualitative and quantitative proteomic data. Protein-
protein interactions can be analyzed directly by precipitation of a tagged
bait followed by mass spectrometric identification of its binding partners.
By these and similar strategies, entire protein complexes, signaling pathw
ays, and whole organelles are being characterized. Posttranslational modifi
cations remain difficult to analyze but are starting to yield to generic st
rategies.